Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) Net Margin (2016 - 2025)

Bio-Techne (TECH) has 17 years of Net Margin data on record, last reported at 12.85% in Q4 2025.

  • For Q4 2025, Net Margin rose 110.0% year-over-year to 12.85%; the TTM value through Dec 2025 reached 2.46%, up 386.0%, while the annual FY2025 figure was 1.82%, 240.0% up from the prior year.
  • Net Margin reached 12.85% in Q4 2025 per TECH's latest filing, down from 13.33% in the prior quarter.
  • Across five years, Net Margin topped out at 4486.7% in Q3 2022 and bottomed at 43.85% in Q2 2024.
  • Average Net Margin over 5 years is 233.18%, with a median of 14.75% recorded in 2024.
  • Peak YoY movement for Net Margin: soared 445993bps in 2022, then plummeted -446829bps in 2023.
  • A 5-year view of Net Margin shows it stood at 26.76% in 2021, then plummeted by -31bps to 18.41% in 2022, then plummeted by -45bps to 10.08% in 2023, then increased by 17bps to 11.75% in 2024, then grew by 9bps to 12.85% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 12.85% in Q4 2025, 13.33% in Q3 2025, and 21.72% in Q2 2025.